HER3-DXd

🧬 Interested in pharma, biotech and medical device news? Visit PharmaDeviceNews.com →

Business news, market intelligence, and global industry analysis.

The Latest

Representative image of an offshore drilling rig near Namibia’s coast at sunset, illustrating bp plc’s entry into the Walvis Basin through its Eco Atlantic Oil & Gas block acquisition.

ONGC gives Transocean $300m India contract that could keep KG2 busy into 2031

Vitestro’s Aletta robotic blood-draw system has received U.S. Food and Drug Administration De Novo authorization, opening a new regulatory pathway for autonomous phlebotomy as laboratories weigh whether robotic blood collection can scale economically and operationally. Representative image.

Vitestro wins FDA De Novo authorization for Aletta robotic blood draw system

Baidu’s second-quarter 2026 results highlight the tension in its AI transition, with AI Cloud Infrastructure revenue rising 50% and GPU Cloud revenue surging 283% even as legacy businesses weakened and total revenue declined 4%. Representative image.

Baidu GPU cloud surges 283%, but investors punish unfinished AI transition

A66 wrong-way crash kills seven including two Cleveland Police officers near Middlesbrough

HER3-DXd shows promise in treating brain metastases: Inside the TUXEDO-3 trial results from ASCO 2025

HER3-DXd from Daiichi Sankyo and Merck shows intracranial activity in CNS cancers, as TUXEDO-3 results presented at ASCO 2025 spark major oncology interest.

μFR system
αvβ6-integrin
α4β7 integrin
Zywie Ventures
ZYUS Life Sciences
Zyrtec
Zyprexa Zydis
Zynyz
ZYNRELEF
Zynga

May 31, 2025